Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction
Hye Jin Wang(Yonsei University), Eun Seok Kang(Korea University)
Cited by 57
Related Papers
Pharmacotherapy of type 2 diabetes: An update
|Metabolism|2017|187
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
|Metabolism|2020|136
Effects of leptin and adiponectin on pancreatic β-cell function
|Metabolism|2011|128
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
|The American Journal of Gastroenterology|2020|112